Merus and Halozyme Join Forces to Enhance Subcutaneous Cancer Treatment Options Merus and Halozyme have announced a collaboration to develop a subcutaneous formulation of petosemtamab, aiming to improve cancer treatment delivery methods.

Merus and Halozyme Join Forces to Enhance Subcutaneous Cancer Treatment Options #United_States #San_Diego #Halozyme #Merus #Petosemtamab